Chloride-guided bolus vs conventional fluid therapy for preoperative optimisation in infantile hypertrophic pyloric stenosis.

TL;DR

A targeted fluid resuscitation approach guided by serum chloride levels reduced time to metabolic correction from 71 hours to 7 hours and shortened hospital stays by 36 hours in infants with infantile hypertrophic pyloric stenosis, with no safety concerns reported.

What the Study Found

Infantile hypertrophic pyloric stenosis (IHPS) is a surgical condition affecting infants aged 2-12 weeks, characterized by thickening of the muscle controlling the outlet from the stomach. These infants present with severe vomiting that rapidly depletes fluids and electrolytes, creating a dangerous metabolic state before surgery can be performed. Current standard practice uses conventional fluid therapy (CFT), which applies a fixed protocol of maintenance fluids with potassium supplementation and periodic lab monitoring every six hours. This approach is safe but slow, often requiring 48-72 hours to achieve the metabolic stability needed for safe anesthesia.

Researchers at a tertiary surgical center in Pakistan tested an alternative strategy: chloride-guided bolus fluid therapy (BFT). This approach delivers larger volumes of saline more rapidly, with dosing tailored to each infant's serum electrolytes, specifically chloride and bicarbonate levels, using the Dalton algorithm as a decision-making framework. The strategy prioritizes faster correction of the specific electrolyte abnormalities present rather than following a one-size-fits-all timeline. In a randomized controlled trial with 100 infants split evenly between groups, the bolus approach achieved biochemical optimization in 7.1 hours compared to 71.5 hours with conventional therapy. Hospital stay was reduced from 154.5 hours to 118.6 hours (roughly 36 hours shorter), and the number of laboratory tests needed dropped from 4.8 to 3.2 per infant. Importantly, no adverse events occurred in either group, indicating the more aggressive bolus approach carried no safety penalty in this population.

The mechanism behind the improvement is mechanically straightforward: larger, targeted fluid volumes correct electrolyte abnormalities faster than gradual replacement. However, the specificity of the chloride-guided approach matters. Rather than applying a generic resuscitation formula, clinicians used baseline lab values to calculate precisely how much saline each infant needed. This personalization reduced waste and unnecessary testing. The study was conducted in a resource-limited setting (Pakistan), where reducing hospital length of stay has additional benefits: lower infection risk from prolonged hospitalization, reduced family burden, and more efficient use of surgical capacity.

What This Means for You

This research is directly relevant only to parents and clinicians managing IHPS in infants, not to general health decision-making. If your infant is diagnosed with IHPS, this study demonstrates that faster resuscitation using chloride-guided bolus therapy is both safe and more efficient than conventional slow rehydration. Discuss with your surgical team whether they use chloride-guided protocols or conventional approaches, and understand that the choice significantly impacts preoperative timeline and hospital stay duration. In resource-limited settings, this approach may be especially valuable for reducing unnecessary hospitalization.

For clinicians managing IHPS: the evidence supports adoption of chloride-guided bolus therapy as an alternative to conventional protocols, particularly if your center has capacity for rapid turnaround of electrolyte testing. The approach requires more intensive monitoring around each bolus but reduces total testing burden and dramatically shortens time to surgical readiness.

Study Details

Sources

Primary Study:

Chloride-guided bolus vs conventional fluid therapy for preoperative optimisation in infantile hypertrophic pyloric stenosis. Annals of the Royal College of Surgeons of England. PubMed: 41556213